← Open Payments lookup

ARLENE SCORSONE: Open Payments

NPI 1295410710 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$415 in 26 payments from 12 companies in 2025. Trend: 2023 $23 · 2024 $323 · 2025 $415

Food & beverage: $415
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$163
Madrigal Pharmaceuticals2$37
Takeda Pharmaceuticals U.S.A., Inc.1$30
La Jolla Pharmaceutical Company1$28
ORPHALAN INC1$24
Intercept Pharmaceuticals, Inc.1$24
Eton Pharmaceuticals, Inc.1$22
Kerecis Limited1$22
Novo Nordisk Inc1$18
Celltrion USA Inc.1$18

Products named: XIFAXAN, REZDIFFRA, LIVTENCITY, GIAPREZA, CUVRIOR, OCALIVA, GALZIN, Kerecis SurgiClose.

Industry payments across TX — which companies pay providers there.